Cassava Sciences Inc (SAVA)
25.84
-0.37
(-1.41%)
USD |
NASDAQ |
Nov 04, 16:00
26.00
+0.16
(+0.62%)
After-Hours: 20:00
Cassava Sciences Cash from Operations (Quarterly): -18.24M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -18.24M |
| March 31, 2024 | -19.13M |
| December 31, 2023 | -22.32M |
| September 30, 2023 | -26.53M |
| June 30, 2023 | -19.92M |
| March 31, 2023 | -13.26M |
| December 31, 2022 | -21.32M |
| September 30, 2022 | -21.55M |
| June 30, 2022 | -11.11M |
| March 31, 2022 | -23.53M |
| December 31, 2021 | -7.987M |
| September 30, 2021 | -14.76M |
| June 30, 2021 | -5.139M |
| March 31, 2021 | -2.306M |
| December 31, 2020 | -1.175M |
| September 30, 2020 | -2.171M |
| June 30, 2020 | -0.842M |
| March 31, 2020 | -1.194M |
| December 31, 2019 | -0.589M |
| September 30, 2019 | -0.73M |
| June 30, 2019 | -0.591M |
| March 31, 2019 | -0.604M |
| December 31, 2018 | -0.565M |
| September 30, 2018 | -1.436M |
| June 30, 2018 | -1.126M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.643M |
| December 31, 2017 | -1.437M |
| September 30, 2017 | -2.151M |
| June 30, 2017 | -3.197M |
| March 31, 2017 | -1.452M |
| December 31, 2016 | -3.031M |
| September 30, 2016 | -2.787M |
| June 30, 2016 | -3.274M |
| March 31, 2016 | -3.142M |
| December 31, 2015 | -3.548M |
| September 30, 2015 | -2.41M |
| June 30, 2015 | -1.948M |
| March 31, 2015 | -1.147M |
| December 31, 2014 | -2.563M |
| September 30, 2014 | -1.672M |
| June 30, 2014 | -2.591M |
| March 31, 2014 | -2.723M |
| December 31, 2013 | -1.454M |
| September 30, 2013 | -1.819M |
| June 30, 2013 | -1.801M |
| March 31, 2013 | -1.873M |
| December 31, 2012 | -1.854M |
| September 30, 2012 | -1.297M |
| June 30, 2012 | -1.95M |
| March 31, 2012 | -2.07M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-26.53M
Minimum
Sep 2023
-0.589M
Maximum
Dec 2019
-12.27M
Average
-13.26M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 5.591B |
| Eli Lilly and Co | 3.712B |
| Seelos Therapeutics Inc | -0.972M |
| Biomarin Pharmaceutical Inc | 221.48M |
| EyePoint Pharmaceuticals Inc | -20.18M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.029M |
| Cash from Financing (Quarterly) | 101.39M |
| Free Cash Flow | -86.31M |
| Free Cash Flow Per Share (Quarterly) | -0.3954 |
| Free Cash Flow Yield | -7.66% |